Matrix remodelling enzymes, the protease cascade and glycosylation

Biochimica et Biophysica Acta- General Subjects

Volumn 1528, Issue 2-3, 2001, Pages 61-73

  Van den Steen, Philippe E ^a   Opdenakker, Ghislain ^a   Wormald, Mark R ^b   Dwek, Raymond A ^b   Rudd, Pauline M ^b  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Collagenase MMP 1; Gelatinase B MMP 9; Plasminogen; Sialic acid; Stromelysin 1 MMP 3; TIMP 1; Tissue type plasminogen activator; Urokinase

Indexed keywords

CARBOHYDRATE; COLLAGENASE; ENZYME PRECURSOR; FIBRIN; GELATINASE A; GELATINASE B; GLYCOPROTEIN; MATRIX METALLOPROTEINASE; OLIGOSACCHARIDE; PLASMIN; PLASMINOGEN; SERINE PROTEINASE; SIALIC ACID; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE PLASMINOGEN ACTIVATOR;

CATALYST; COMPARATIVE STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME MODIFICATION; ENZYME STRUCTURE; EXTRACELLULAR MATRIX; GLYCOSYLATION; HUMAN; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW;

ANIMALS; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; GLYCOSYLATION; HUMANS; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MODELS, MOLECULAR; POLYSACCHARIDES; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; SERINE ENDOPEPTIDASES;

EID: 0035802280     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(01)00190-8     Document Type: Review

References (60)

1. Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system
2. The effects of variable glycosylation on the functional activities of ribonuclease, plasminogen and tissue plasminogen activator
3. Structure of human plasminogen kringle 4 at 1.68 angstrom and 277 K. A possible structural role of disordered residues
4. Solution structure of the amino-terminal fragment of urokinase-type plasminogen activator
5. The crystal structure of the catalytic domain of human urokinase-type plasminogen activator
6. Solution structure and dynamics of the plasminogen kringle 2-AMCHA complex: 3(1)-helix in homologous domains
7. The structure of recombinant plasminogen kringle 1 and the fibrin binding site
8. Structure and ligand binding determinants of the recombinant kringle 5 domain of human plasminogen
9. Human plasminogen catalytic domain undergoes an unusual conformational change upon activation
10. MOLSCRIPT: A program to produce both Detailed and schematic plots of protein structures
11. A statistical analysis of N- and O-glycan linkage conformations from crystallographic data
12. The cysteine switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family
13. Activation of the 92-kDa gelatinase by stromelysin and 4-aminophenylmercuric acetate. Differential processing and stabilization of the carboxyl-terminal domain by tissue inhibitor of metalloproteinases (TIMP)
14. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2)
15. Purification and identification of 91-kDa neutrophil gelatinase. Release by the activating peptide interleukin-8
16. Natural human monocyte gelatinase and its inhibitor
17. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages
18. Generation of biologically active IL-1β by matrix metalloproteinases: A novel caspase-1-independent pathway of IL-1β processing
19. Processing of tumour necrosis factor-α precursor by metalloproteinases
20. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact
21. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3
22. Proteolytic inactivation of α1-proteinase inhibitor and α1-antichymotrypsin by oxidatively activated human neutrophil metalloproteinases
23. Cell-type-specific and site-specific N-glycosylation of type I and type II human tissue plasminogen activator
24. Glycobiology
25. Concepts and principles of glycobiology
26. Glycosylation: Heterogeneity and the 3D structure of proteins
27. Concepts and principles of O-linked glycosylation
28. The activation of type 1 and type 2 plasminogen by type I and type II tissue plasminogen activator
29. Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the metalloproteinase gelatinase B (MMP-9)
30. The molecular basis of leukocytosis
31. Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions
32. Gelatinase B modulates selective opening of the blood-brain barrier during inflammation
33. Leukocyte gelatinase B cleavage releases encephalitogens from human myelin basic protein
34. Cytokine-regulated proteases in autoimmune diseases
35. Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system
36. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
37. The serpin α1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo
38. Matrix metalloproteinases
39. The X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity
40. Stromelysin-1: Three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme
41. Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed beta-propeller
42. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1
43. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor
44. Structure of human pro-matrix metalloproteinase-2: Activation mechanism revealed
45. Structural characterization of the catalytic active site in the latent and active natural gelatinase B from human neutrophils
46. Crystal structures of MMP-1 and-13 reveal the structural basis for selectivity of collagenase inhibitors
47. The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction
48. Kinetic analysis of the binding of human matrix metalloproteinase-2 and-9 to tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2
49. O-Glycan analysis of natural human neutrophil gelatinase B using a combination of normal phase-HPLC and online tandem mass spectrometry: Implications for the domain organization of the enzyme
50. Glycosylation of natural human neutrophil gelatinase B and neutrophil gelatinase B-associated lipocalin
51. Oligosaccharides of recombinant mouse gelatinase B variants
52. Effects of glycosylation on the conformation and dynamics of O-linked glycoproteins: Carbon-13 NMR studies of ovine submaxillary mucin
53. N-Glycan structures of matrix metalloproteinase-1 derived from human fibroblasts and from HT-1080 fibrosarcoma cells
54. Cell-specific glycoforms of sialoadhesin and CD45 are counter-receptors for the cysteine-rich domain of the mannose receptor
55. Strategies for optimal synthesis and secretion of heterologous proteins in the methylotrophic yeast Pichia pastoris
56. Identification of peptide:N-glycanase activity in mammalian-derived cultured cells
57. The substrate specificity of the enzyme endo-α-N-acetyl-D-galactosaminidase from Diplococcus pneumonia
58. Expression, purification, crystallization and crystallographic characterization of dimeric and monomeric human neutrophil gelatinase associated lipocalin (NGAL)
59. Kinetic comparison of peptide: N-glycosidases F and A reveals several differences in substrate specificity
60. The behavior and significance of slow-binding enzyme inhibitors